Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wolfe Research Downgrades Scholar Rock Holding to Peer Perform
Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript
What Scholar Rock (SRRK) Said on Its Q3 Earnings Call
What Scholar Rock Holding (SRRK)'s ISEMBYLD Launch Means For Shareholders
Scholar Rock (NASDAQ:SRRK) Q3 2026 Results: ISEMBYLD Launch, Revenue Beat, and Stock Pullback
Scholar Rock Holding Corporation (SRRK) Q3 2026 Earnings Call Transcript
Scholar Rock Holding Corporation (SRRK) Reports Q3 Loss, Beats Revenue Estimates
Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Scholar Rock Holding Q3 2026 Earnings Call Transcript
Scholar Rock Holding Q3 EPS $(0.81) Beats $(0.85) Estimate, Sales $600.000K Beat $22.429K Estimate
Scholar Rock to Present at Upcoming Investor Conferences
Scholar Rock (SRRK) Stock Could Trade At A Premium On Balance Sheet Hopes
Scholar Rock Receives FDA's Priority Review Voucher For Isembyld
Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
EMA Resubmission for Apitegromab Might Change The Case For Investing In Scholar Rock Holding (SRRK)
Scholar Rock Refiles Marketing Authorisation Application With EMA For Apitegromab To Treat Children And Adults With Spinal Muscular Atrophy
Scholar Rock Holding Reports Q2 2026 Results: Full Earnings Call Transcript
Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.